154 related articles for article (PubMed ID: 32732692)
1. Desmoplastic Melanomas Mimicking Neurofibromas.
Gerami P; Kim D; Zhang B; Compres EV; Khan AU; Yazdan P; Guitart J; Busam K
Am J Dermatopathol; 2020 Dec; 42(12):916-922. PubMed ID: 32732692
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.
Elsensohn A; Shiu J; Grove N; Hosking AM; Barr R; de Feraudy S
Am J Surg Pathol; 2018 Mar; 42(3):372-375. PubMed ID: 29112020
[TBL] [Abstract][Full Text] [Related]
3. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics.
Rawson RV; Shteinman ER; Ansar S; Vergara IA; Thompson JF; Long GV; Scolyer RA; Wilmott JS
Pathology; 2022 Dec; 54(7):863-873. PubMed ID: 35987723
[TBL] [Abstract][Full Text] [Related]
5. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
Romano RC; Carter JM; Folpe AL
Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
[TBL] [Abstract][Full Text] [Related]
6. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
7. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
8. A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma.
Weissinger SE; Keil P; Silvers DN; Klaus BM; Möller P; Horst BA; Lennerz JK
Mod Pathol; 2014 Apr; 27(4):524-34. PubMed ID: 24051699
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous desmoplastic melanoma.
Busam KJ
Adv Anat Pathol; 2005 Mar; 12(2):92-102. PubMed ID: 15731577
[TBL] [Abstract][Full Text] [Related]
10. Pigmented neurofibroma: report of two cases and literature review.
Inaba M; Yamamoto T; Minami R; Ohbayashi C; Hanioka K
Pathol Int; 2001 Jul; 51(7):565-9. PubMed ID: 11472571
[TBL] [Abstract][Full Text] [Related]
11. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
12. SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging Case.
Kooper-Johnson S; Mahalingam M; Loo DS
Am J Dermatopathol; 2020 Sep; 42(9):697-699. PubMed ID: 32149837
[TBL] [Abstract][Full Text] [Related]
13. Syringotropic Melanoma: A Diagnostic Challenge With Prognostic Implications.
Torre-Castro J; Haya-Martínez L; Moya-Martínez C; Núñez-Hipólito L; Mendoza-Cembranos MD; Sabaris MDCF; Eraña-Tomás I; Santonja C; Suárez Massa MD; Cerroni L; Requena L
Am J Dermatopathol; 2022 Jan; 44(1):33-36. PubMed ID: 33201009
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint.
Yeh I; McCalmont TH
J Cutan Pathol; 2011 Aug; 38(8):625-30. PubMed ID: 21457155
[TBL] [Abstract][Full Text] [Related]
15. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi.
Shah IA; Gani OS; Wheler L
Pathol Res Pract; 1997; 193(7):497-502. PubMed ID: 9342756
[TBL] [Abstract][Full Text] [Related]
16. Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors.
Lin BT; Weiss LM; Medeiros LJ
Am J Surg Pathol; 1997 Dec; 21(12):1443-9. PubMed ID: 9414187
[TBL] [Abstract][Full Text] [Related]
17. Melanoma Arising From a Pre-existing Neurofibroma in a Patient With No Prior Diagnosis of Systemic Neurofibromatosis 1 or 2: A Case Report.
Nasir W; Howard T; Weiss E
Am J Dermatopathol; 2021 Apr; 43(4):291-293. PubMed ID: 33464751
[TBL] [Abstract][Full Text] [Related]
18. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
19. Acral Spitz Nevi: A Clinicopathologic Study of 50 Cases With Immunohistochemical Analysis of P16 and P21 Expression.
Wiedemeyer K; Guadagno A; Davey J; Brenn T
Am J Surg Pathol; 2018 Jun; 42(6):821-827. PubMed ID: 29537991
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanomas simulating various types of soft tissue tumors.
Zelger BG; Steiner H; Wambacher B; Zelger B
Dermatol Surg; 1997 Nov; 23(11):1047-54. PubMed ID: 9391563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
